A metabolic transition to fructose has also been reported in colorectal cancer and lung adenocarcinoma.6,7 Whether other tumours induce GLUT5 to reprogram their metabolism towards fructose is unknown. This evidence concerns the gene SLC2A5 and neoplasm.